Format

Send to

Choose Destination
See comment in PubMed Commons below
Annu Rev Med. 1995;46:223-34.

Advanced protein glycosylation in diabetes and aging.

Author information

1
Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Abstract

Products of advanced protein glycosylation (advanced glycation end products, or AGEs) accumulate in tissues as a function of time and sugar concentration. AGEs induce permanent abnormalities in extracellular matrix component function, stimulate cytokine and reactive oxygen species production through AGE-specific receptors, and modify intracellular proteins. Pharmacologic inhibition of AGE formation in long-term diabetic animals prevents diabetic retinopathy, nephropathy, neuropathy, and arterial abnormalities in animal models. Clinical trials in humans are currently in progress.

PMID:
7598459
DOI:
10.1146/annurev.med.46.1.223
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center